(Q34522711)

2 August 2017

title

Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis (English)

1 reference

2 August 2017

0 references

Gordon D Raphael

1

1 reference

2 August 2017

James T Angello

series ordinal

2

1 reference

2 August 2017

Mei-Miau Wu

series ordinal

3

1 reference

2 August 2017

Howard M Druce

series ordinal

4

1 reference

2 August 2017

publication date

1 April 2006

1 reference

Annals of Allergy, Asthma & Immunology

2 August 2017

published in

1 reference

2 August 2017

volume

96

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

606-614

1 reference

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

Sedation and performance impairment of diphenhydramine and second-generation antihistamines: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963557-0

7 January 2021

10.1016/S1081-1206(10)63557-0

Identifiers

DOI

1 reference

2 August 2017

1 reference